Other languages Virax Biolabs Group Limited

Equities

VRAX

KYG9495L1251

Market Closed - Nasdaq Other stock markets 03:59:27 2024-06-04 pm EDT			5-day change	1st Jan Change
1.06 ^USD	+1.92%		+19.10%	-27.40%

Apr. 25	Virax Biolabs Launches Portfolio of Immune Profiling Solutions Evaluating Adaptive Immunity in Post-Viral Syndromes at ESCMID Global 2024	CI
Jan. 12	Virax Biolabs Group Limited Reports Earnings Results for the Half Year Ended September 30, 2023	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Virax Biolabs Launches Portfolio of Immune Profiling Solutions Evaluating Adaptive Immunity in Post-Viral Syndromes at ESCMID Global 2024	Apr. 25
Virax Biolabs Group Limited Reports Earnings Results for the Half Year Ended September 30, 2023	Jan. 12
Virax Biolabs Group Limited Forges Strategic Research Collaboration with University of Manchester and Northern Care Alliance Foundation Trust to Enhance Understanding of Immune Responses in COVID Patients	Dec. 21
Top Premarket Gainers	Dec. 12
Virax Biolabs Group Names Nigel McCracken Operating Chief.	23-09-01
Virax Biolabs Group Limited Announces Management Changes	23-09-01
Virax Biolabs Group Limited Signs Contracts to Launch Two New Research and Laboratory Facilities in the United Kingdom	23-07-18
Virax Biolabs Group Limited Reports Earnings Results for the Full Year Ended March 31, 2023	23-06-14
Virax Biolabs Group Limited Auditor Raises 'Going Concern' Doubt	23-06-13
Virax Biolabs Group Limited Announces Establishment of Regional Headquarters at Dubai Science Park	23-05-04
Virax Biolabs Group Limited Enters into an Agreement for the Distribution of Marburg Virus PCR Testing Kits	23-04-19
Traders Cautious Ahead of Powell Testimony, Stifling US Equity futures	23-03-07
Virax Biolabs Signs Agreement to Distribute Avian Influenza A Virus Test Kit in the European Union; Shares Surge Pre-Bell	23-03-07
Top Premarket Gainers	23-03-07
Virax Biolabs Group Limited Enters into an Agreement for the Distribution of an Avian Influenza A Virus	23-03-07
Top Premarket Gainers	23-02-27
Cosmos Health Sets First Purchase Order for Virax Biolabs' COVID-19, Influenza Tests	23-02-07
Virax Biolabs Group Limited Announces Purchase Order to Launch COVID-19 and Influenza A+B Antigen Combo Rapid Tests with Cosmos Health	23-02-07
Virax Biolabs Group Limited Announces Purchase Order to Launch COVID-19 and Influenza A+B Antigen Combo Rapid Tests with Cosmos Health	23-02-07
Virax Biolabs Group Limited Reports Earnings Results for the Half Year Ended September 30, 2022	23-02-02

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Virax Biolabs Group Limited

Equities

VRAX

KYG9495L1251

Other languages

Filters